It’s still relatively early days for the IA Global Emerging Market Bond sector,...
Janus Henderson has re-jigged its bond team with the hire of Columbia Threadneedle’s Jim Cielinski as global head of fixed income.
The result of the weekend’s St Leger horse race was the worst result of the season for the bookmarker William Hill, after the favourite 3/1 bet Capri took victory.
Smith & Williamson has strengthened its outsourced investment services team with the hire of Matthew Finch from Barings.
Axa Investment Managers has launched a China short duration bond fund, which aims to give investors exposure to the 56trn renminbi (€7trn) bond market.
Global fund managers upped their emerging markets overweight to a net 47% in September, while increasing their underweight to the US, according to the latest Bank of America (BofA) Merrill Lynch survey.
Investors continued to shun UK equities in July, instead preferring to invest globally and in corporate bonds, according to the latest Investment Association statistics.
UK retail investors have often been accused of investing too much in the domestic market, and research published today suggests that by doing so they have missed out on significant gains elsewhere.
In an environment in which the UK economy is set to underperform the rest of the world in the medium to long term, Sanlam argues UK investors should once again turn their attention to large caps.
Despite significantly outperforming developed markets for the past two years, discounts in the emerging market investment trust sector remain in double-digit territory, according to broker Stifel.
Baillie Gifford has reduced annual management charges across its range of UK Oeics and Irish Ucits funds, with effect from 1 October 2017.
Co-founder of Hargreaves Lansdown Peter Hargreaves is set to invest £25m of his money into a new fund managed by former colleague Stephen Yiu.
Fulcrum Asset Management has added to its multi-asset team with the hire of Marc Semaan from Aviva Investors’ AIMS team.
Political talk has cast a shadow over biotech stock prices. And yet the sector has...